When mammary tumors were pretreated with image-guided fractionated radiation therapy (IGRT) followed by anti-TAG72-IL-2 therapy, an improved tumor growth inhibition was observed along with an increased tumor infiltration of IFNγ+ CD8+ T cells and a significant reduction in Foxp3+ CD4+ cells. This evidence concerns the gene FOXP3 and neoplasm.